Literature DB >> 16340941

Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines.

Tejpratap Tiwari, Trudy V Murphy, John Moran.   

Abstract

The recommendations in this report were developed to broaden the spectrum of antimicrobial agents that are available for treatment and postexposure prophylaxis of pertussis. They include updated information on macrolide agents other than erythromycin (azithromycin and clarithromycin) and their dosing schedule by age group.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16340941

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN： 1057-5987


  61 in total

1.  Peptidoglycan Recognition Protein 4 Suppresses Early Inflammatory Responses to Bordetella pertussis and Contributes to Sphingosine-1-Phosphate Receptor Agonist-Mediated Disease Attenuation.

Authors:  Ciaran Skerry; William E Goldman; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

2.  Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method.

Authors:  N K Fry; J Duncan; L Vaghji; R C George; T G Harrison
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-03       Impact factor: 3.267

3.  Clinical characteristics and pertussis costs in cases reported to epidemiological services and cases detected in household contacts in Catalonia (Spain).

Authors:  P Plans; C Muñoz-Almagro; P Godoy; M Jané; G Carmona
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-30       Impact factor: 3.267

4.  Parental attitude towards mass antimicrobial prophylaxis during a school-associated pertussis outbreak.

Authors:  S M Borchardt; G Polyak; M S Dworkin
Journal:  Epidemiol Infect       Date:  2006-06-06       Impact factor: 2.451

5.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 6.  Pertussis vaccination for health care workers.

Authors:  Thomas J Sandora; Courtney A Gidengil; Grace M Lee
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

7.  Balancing competing risks: perinatal exposure to macrolides increases the risk of infantile hypertrophic pyloric stenosis.

Authors:  Margaret A Honein; Janet D Cragan
Journal:  Evid Based Med       Date:  2014-08-13

8.  Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review.

Authors:  Kazeem A Oshikoya; Gerold T Wharton; Debbie Avant; Sara L Van Driest; Norman E Fenn; Allison Lardieri; Edwin Doe; Beena G Sood; Carol Taketomo; Phuong Lieu; Lilly Yen; Ann W McMahon
Journal:  Paediatr Drugs       Date:  2019-02       Impact factor: 3.022

Review 9.  Strategies to control trachoma.

Authors:  Anu A Mathew; Angus Turner; Hugh R Taylor
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

10.  Pertussis in early life: underdiagnosed, severe, and risky disease. A seven-year experience in a pediatric tertiary-care hospital.

Authors:  Chiara Di Camillo; Anna Chiara Vittucci; Livia Antilici; Claudia Ciarlitto; Giulia Linardos; Carlo Concato; Laura Lancella; Alberto Villani
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.